GRI Bio (GRI) Change in Acquisitions & Divestments (2022)
GRI Bio (GRI) posted quarterly Change in Acquisitions & Divestments of $420000.0 for Q4 2022, down 71.62% quarter-over-quarter from $1.5 million in Q3 2022.
GRI Bio (GRI) Change in Acquisitions & Divestments (2022) Analysis & Trends
GRI Bio's Change in Acquisitions & Divestments history runs 1 years deep, the most recent figure standing at $420000.0 for Q4 2022.
- In Q4 2022, Change in Acquisitions & Divestments changed N/A year-over-year to $420000.0; the TTM figure through Mar 2023 stood at $3.3 million (up 183.19% YoY), while the FY2022 annual figure was $4.4 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments for Q4 2022 stood at $420000.0, down from $1.5 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $1.5 million in Q3 2022, with the low at $420000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GRI Bio | 3.01 Mn | 3.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 420,000.00 |
| Dec 31, 2022 | 420,000.00 |
| Sep 30, 2022 | 1.48 Mn |
| Sep 30, 2022 | 1.48 Mn |
| Jun 30, 2022 | 1.37 Mn |
| Jun 30, 2022 | 1.37 Mn |
| Mar 31, 2022 | 1.15 Mn |
| Mar 31, 2022 | 1.15 Mn |